myTomorrows is a platform that helps patients and physicians discover and access treatments in development. We conduct a comprehensive search of databases worldwide and then provide patients and physicians with a personalized Treatment Search Report listing possible treatment options, such as clinical trials and expanded access programs. When patients and physicians decide to pursue one of these options, we may be able to facilitate access for them. We have helped more than 5,000 patients and 500 physicians in over 80 countries. Our multi-functional digital platform serves patients, healthcare professionals (HCPs) and pharmaceutical companies in an efficient and compliant way — and helps bridge the gaps between these three stakeholders. Our new HCP Portal helps HCPs by quickly identifying potential pre-approval treatment options (clinical trials and expanded access programs) and more efficiently facilitating access to them. The portal features Treatment Search, our proprietarily developed tool that allows physicians to search global registries to find clinical trials and expanded access programs and filter results based on individual needs. myTomorrows was founded in 2012 by Ronald Brus, MD, after losing his father to lung cancer. As a physician and founder of biotech companies, he thought he could help his father access a treatment in development, but he was surprised at how complicated and slow the process was. He dedicated himself to creating an easier way for patients to access treatments in development. Headquartered in Amsterdam with an office in New York City, myTomorrows now employs more than 50 people. Our services of providing information about treatment options and how to access them are always free of charge for patients and physicians. We charge pharmaceutical companies for our services, which include managing international expanded access programs, facilitating real-world data collection and supporting clinical trial recruitment.